BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1884564)

  • 21. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study.
    Bacci G; Ferrari S; Longhi A; Picci P; Mercuri M; Alvegard TA; Saeter G; Donati D; Manfrini M; Lari S; Briccoli A; Forni C;
    J Chemother; 2002 Apr; 14(2):198-206. PubMed ID: 12017378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen.
    Ferrari S; Sassoli V; Orlandi M; Strazzari S; Puggioli C; Battistini A; Bacci G
    J Chemother; 1993 Apr; 5(2):135-41. PubMed ID: 8515297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 24. Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.
    Ogihara Y; Sudo A; Fujinami S; Sato K; Miura T
    Clin Orthop Relat Res; 1991 Sep; (270):72-8. PubMed ID: 1884562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study.
    Bacci G; Ruggieri P; Picci P; Mercuri M; Ferraro A; Tella G; Ferrari S; Bertoni F; Comandone A
    J Chemother; 1996 Feb; 8(1):70-81. PubMed ID: 8835114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities.
    Bacci G; Picci P; Avella M; Ferrari S; Casadei R; Ruggieri P; Brach del Prevert A; Tienghi A; Battistini A; Mancini A
    J Chemother; 1992 Jun; 4(3):189-95. PubMed ID: 1517815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
    Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
    Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.
    Bacci G; Ferrari S; Mercuri M; Longhi A; Fabbri N; Galletti S; Forni C; Balladelli A; Serra M; Picci P
    Acta Orthop; 2007 Jun; 78(3):377-84. PubMed ID: 17611853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
    Picci P; Bacci G; Ferrari S; Mercuri M
    Ann Oncol; 1997 Nov; 8(11):1107-15. PubMed ID: 9426330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life.
    Bacci G; Ferrari S; Donati D; Longhi A; Bertoni F; Di Fiore M; Comandone A; Cesari M; Campanacci M
    Oncol Rep; 1998; 5(5):1259-63. PubMed ID: 9683847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
    Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
    Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
    Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
    J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update of Scandinavian studies of osteosarcoma.
    Elomaa I
    Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
    [No Abstract]   [Full Text] [Related]  

  • 38. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy,
    Bacci G; Ferrari S; Bertoni F; Picci P; Bacchini P; Longhi A; Donati D; Forni C; Campanacci L; Campanacci M
    Clin Orthop Relat Res; 2001 May; (386):186-96. PubMed ID: 11347833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.
    Bacci G; Ferrari S; Mercuri M; Longhi A; Capanna R; Tienghi A; Brach del Prever A; Comandone A; Cesari M; Bernini G; Picci P
    Acta Oncol; 1998; 37(1):41-8. PubMed ID: 9572653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.